基于NNMT甲基化通路与表观遗传学研究潜阳育阴方对高血压肾损伤的影响及机制

基本信息
批准号:81573909
项目类别:面上项目
资助金额:59.00
负责人:方祝元
学科分类:
依托单位:南京中医药大学
批准年份:2015
结题年份:2019
起止时间:2016-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:杨勤,刘鸣,储继红,周锦勇,陈艺,丁康,李婕,袁方
关键词:
潜阳育阴方烟酰胺N甲基转移酶肾损伤高血压表观遗传学
结项摘要

Renal injury is the main complication of hypertension. However, the underlying mechanism of hypertensive renal injury is unclear. Nicotinamide N-methyltransferase (NNMT) can regulate H3K4 methylation, Sirt1 mediated histone deacetylation and DNA methylation, which in turn might play an important role in hypertensive renal injury. Qianyangyuyin formula is an experimental formula of Tang-shuhua, the famous old TCM doctors in our hospital. Although both clinical trials and laboratory research have confirmed the beneficial effects of Qianyangyuyin formula on hypertensive renal injury, the underlying mechanism remains to be clarified. We found that NNMT activity was positively associated with decreased renal function in hypertensive patients. Therefore, we propose that NNMT regulated epigenetic pathway is the main molecular mechanism of hypertensive renal injury, and Qianyangyuyin formula may treat hypertensive renal injury via modulating such pathway. Based on our hypothesis, the present study would be conducted in vivo and in vitro, from mRNA and protein cellular levels, as well as cell and histomorphological levels, to investigate the effects of Qianyangyuyin formula on NNMT activity and related epigenetic modifications via using immunohistochemistry, qPCR and Western Blot techniques.

肾损伤是高血压的主要并发症,其内在的机制尚不完全清楚。研究表明,烟酰胺-N-甲基转移酶(NNMT)调控的H3K4组蛋白甲基化、Sirt1组蛋白去乙酰化和DNA甲基化等表观遗传学修饰可能是高血压肾损伤的重要分子机制。潜阳育阴方是我院名老中医唐蜀华教授经验方,临床和实验研究均证明具有治疗高血压肾损伤作用,但其作用机制尚有待于进一步深入。我们前期发现高血压患者中NNMT活性升高与肾功能下降相关。据此,我们提出NNMT活性升高调控的表遗传修饰是导致高血压肾损伤的主要机制,潜阳育阴方通过调控NNMT表遗传修饰通路治疗高血压肾损伤。根据以上科学假说,本项目拟结合体内、体外模型,采用免疫组化、qPCR、Western Blot等实验技术,从mRNA、蛋白水平及细胞、组 织形态学等不同层次多角度验证潜阳育阴方在高血压肾损伤调控中的作用方式和调节NNMT的表观遗传学机制,解析其发挥功能效应的途径及作用靶点。

项目摘要

肾损伤是高血压的主要并发症,其内在的机制尚不完全清楚。研究表明,烟酰胺-N-甲基转移酶(NNMT)调控的H3K4组蛋白甲基化、Sirt1组蛋白去乙酰化和DNA甲基化等表观遗传学修饰可能是高血压肾损伤的重要分子机制。潜阳育阴方是我院名老中医唐蜀华教授经验方,临床和实验研究均证明具有治疗高血压肾损伤作用,但其作用机制尚有待于进一步深入。我们前期发现高血压患者中NNMT活性升高与肾功能下降相关。据此,我们提出NNMT活性升高调控的表遗传修饰是导致高血压肾损伤的主要机制,潜阳育阴方通过调控NNMT表遗传修饰通路治疗高血压肾损伤。根据以上科学假说,本项目拟结合体内、体外模型,采用免疫组化、qPCR、Western Blot等实验技术,从mRNA、蛋白水平及细胞、组 织形态学等不同层次多角度验证潜阳育阴方在高血压肾损伤调控中的作用方式和调节NNMT的表观遗传学机制,解析其发挥功能效应的途径及作用靶点。结果显示潜阳育阴颗粒改善SHR大鼠高血压肾损伤,抑制HEK293T细胞增殖,细胞层面上进一步验证NNMT为H3K4甲基化、cortactin乙酰化上游因子,潜阳育阴颗粒通过抑制NNMT活性,调控NNMT相关底物、反应产物以及代谢物发挥肾保护作用。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

坚果破壳取仁与包装生产线控制系统设计

坚果破壳取仁与包装生产线控制系统设计

DOI:10.19554/j.cnki.1001-3563.2018.21.004
发表时间:2018
2

Identification of the starting reaction position in the hydrogenation of (N-ethyl)carbazole over Raney-Ni

Identification of the starting reaction position in the hydrogenation of (N-ethyl)carbazole over Raney-Ni

DOI:
发表时间:2015
3

One-step prepared prussian blue/porous carbon composite derives highly efficient Fe-N-C catalyst for oxygen reduction

One-step prepared prussian blue/porous carbon composite derives highly efficient Fe-N-C catalyst for oxygen reduction

DOI:10.1016/j.ijhydene.2020.03.250
发表时间:2020
4

Ultrafine Fe/Fe_3C decorated on Fe-N_x-C as bifunctional oxygen electrocatalysts for efficient Zn-air batteries

Ultrafine Fe/Fe_3C decorated on Fe-N_x-C as bifunctional oxygen electrocatalysts for efficient Zn-air batteries

DOI:10.1016/j.jechem.2020.07.048
发表时间:2021
5

聚酰胺酸盐薄膜的亚胺化历程研究

聚酰胺酸盐薄膜的亚胺化历程研究

DOI:10.3969/j.issn.1005-5770.2022.09.012
发表时间:2022

相似国自然基金

1

基于TRPC6/CaMKKβ/AMPK/mTOR信号通路探讨潜阳育阴颗粒调控肾脏自噬水平治疗高血压肾损伤的机制

批准号:81904113
批准年份:2019
负责人:李婕
学科分类:H3108
资助金额:20.00
项目类别:青年科学基金项目
2

潜阳育阴方调控肾脏花生四烯酸代谢网络及前列腺素功能紊乱治疗高血压肾损伤的机制研究

批准号:81273713
批准年份:2012
负责人:方祝元
学科分类:H3108
资助金额:70.00
项目类别:面上项目
3

活血潜阳方对高血压大鼠心肌间质重构调控网络的影响

批准号:30572381
批准年份:2005
负责人:符德玉
学科分类:H3108
资助金额:24.00
项目类别:面上项目
4

原发性骨质疏松症DBP基因多态性及滋肾阴方、温肾阳方作用机制研究

批准号:81730107
批准年份:2017
负责人:王拥军
学科分类:H33
资助金额:290.00
项目类别:重点项目